Week 338 Review - It just keeps getting worse

Every week in 2022 has seen a fall in portfolio value. Despite OPTI:Optibiotix staying flat for the 2nd week in a row, there were big drops across the rest of the portfolio and the deficit between cost and value widened by £1,430 to an eye-watering £59,629 and overall portfolio value dropped to £96,171. The only relief is that it went much worse earlier in the week but rallied at the end. It's still a new record deficit though.

JLP:Jubilee Metals was the worst performer, slipping 23% of my original purchase price. I expected this to be at least 20p by now, but instead it's 14.7p.

POLY:Polymetal is getting hammered thanks to the Russians lurking on the Ukrainian border, but the gold price also slumped at the end of the week. These are down 10% which isn't supposed to happen to my magic formula shares.

BLU:Blue Star Capital is sliding rapidly after the recent spike. It fell another 15% this week to go 56% down.

CEY:Centamin fell 7% as the gold price slipped, and PAF:Pan African Resources dropped 6%, with the Blackrock World Gold Fund also falling 6% and HUM:Hummingbird Resources 5% as gold dropped. Frustratingly the gold price didn't drop that much, but it didn't stop all my miners being hit.

Share of the Week SMS:Smart Metering Systems hardly warrants the prize, rising just 2%, but if was further than the other four companies that ended the week higher than they started.

Injection line here we come - the mattress would have done the job after all

Well below the steep downward-facing trend line

Here's the ISA and shares portfolio after week 26 of year 7.

			Weekly Change
Cash	£33.30		+£0
Portfolio cost	£72,195.21		+£0
Portfolio sell value (bid price-commission)	£44,632.32	(-38.2%)	-£713.37
Potential profits	£2,055.29		-£200
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,664.29		+£0
Yr 7 projected avg monthly profit	£611.28	(16.6%)	-£24.45
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,788.23		+£0
Average monthly cash profit	£369.91	(10.0%)	-£1.10
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	65%		+0%

Drop in potential profits thanks to JLP:Jubilee Metals, and relatively big drop in value considering OPTI:Optibiotix stayed flat. The 4% drop in DDDD:4D Pharma was a major contributor, and amazingly it came in a week that positive test results were announced for their asthma drug. So much for "this will bounce when we get good news".

Long term performance has dropped to 10% which is bang on target, but in a few weeks we'll slip below. Year 7 is still pretty good, and if I don't sell anything else in the next 6 months will give 8.3%, which given the state of my portfolio would be quite a good year.

As with the overall account, in severe danger of crossing the injection line.

A long way below the trend line
The SIPP looks like this after week 322 overall and week 10 of year 7.

			Weekly Change
Cash	£411.63		+£200.03
Portfolio cost	£80,526.94		+£0
Portfolio sell value (bid price - commission)	£50,089.86	(-37.8%)	-£661.00
Potential profits	£67.27		-£65.92
Yr 7 Dividends	£81.54		+£30.03
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£381.04		+£0
Yr 7 projected avg monthly profit	£185.93	(4.5%)	-£6.20
Total Dividends	£3,285.93		+£30.03
Total Interest	£0.20		+£0
Total Profit from sales	£24,105.67		+£0
Average monthly cash profit	£357.11	(8.7%)	-£0.71
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	54%		+0%

£170 tax rebate boosted cash, and £30 dividends came from CMCL:Caledonia Mining (£15), FXPO:Ferrexpo (£7) and SMS:Smart Metering Systems (£7). Potential profits were halved thanks to PAF:Pan African Resources and long term performance just dropped a little.

Same old story

A bit closer to the trend line but still below.

The trading account looks like this after week 288 overall and week 28 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£744.77	(-68.6%)	-£56.17
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.02	(7.6%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

What can I say? Yet another desperately bad week. Big drops and no hope.

I had to drop the Y access to £500 so we can watch the continued fall.

It was following the trend line down, but now it's dragging it steeper.

Not saying anything else. Every time there has been good news the share price has fallen further. There's nothing going to improve until we get out of this current malaise in stock markets.

Week 337 Review - Worse than the worst ever

If last week was the worst ever, then this week is even worse, albeit only £363 worse, which would normally be regarded as a flat week if it didn't result in the worst ever performance. The deficit between cost and value now stands at £58,198 and portfolio value is £97,401.

SBTX:SkinBioTherapeutics was the biggest loser, falling 8% in my ISA and 9% in my SIPP to go 34% down in just a few weeks since I bought them. My original plan was to try and buy back around 30p but I really didn't think they would fall that far.

FXPO:Ferrexpo fell 7% for the 2nd week in a row, no doubt fueled by the threat of a Russian invasion of Ukraine. They are now 46% down from when I bought them at what I thought was a bargain price. They've already yielded 5% dividend and more is due next Friday, so as long as they recover by May I'll have made an excellent return.

SMS:Smart Metering Systems has been dropping ever since the 800p placing. They fell 6% this week to 735p so those taking part in the placing are probably a bit miffed. My holding is 23% down and my dividend so far is only 0.7% but there will be another payout next week to give this a little boost.

BLU:Blue Star Capital was well and truly pumped recently but is now dropping like a stone. It went down 5% this week to go 41% down altogether. SatoshiPay had better work out as I want to be rid of them.

IES:Invinity Energy has been dropping steadily as it becomes clear nobody wants their batteries. They fell 5% this week and are 83% down.

There were a few glimmers of hope amongst my gold miners, with CEY:Centaminclimbing 5%, but Share of the Week goes toPAF:Pan African Resources which climbed 7% and at 13% up is one of my very few profitable shares.

Not quite below the injection line - yet.

Still well below the trend line and next week the last memory of being in the black will disappear off the chart.

Here's the ISA and shares portfolio after week 25 of year 7.

			Weekly Change
Cash	£33.30		+£0
Portfolio cost	£72,195.21		+£0
Portfolio sell value (bid price-commission)	£45,345.69	(-37.2%)	-£153.22
Potential profits	£2,255.29		-£20
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,664.29		+£0
Yr 7 projected avg monthly profit	£635.73	(17.3%)	-£27.49
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,788.23		+£0
Average monthly cash profit	£371.01	(10.1%)	-£1.10
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	65%		+0%

Hardly any change. Even the drop in JLP:Jubilee Metals was only enough to drop potential profits by £20.

So, so rubbish

Well below the trend line

The SIPP looks like this after week 321 overall and week 9 of year 7.

			Weekly Change
Cash	£211.60		+£0
Portfolio cost	£80,526.94		+£0
Portfolio sell value (bid price - commission)	£50,750.86	(-37.0%)	-£192.33
Potential profits	£133.19		+£69.56
Yr 7 Dividends	£51.51		+£0
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£381.04		+£0
Yr 7 projected avg monthly profit	£192.13	(4.7%)	-£24.02
Total Dividends	£3,255.90		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£24,105.67		+£0
Average monthly cash profit	£357.82	(8.7%)	-£1.12
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	54%		+0%

Hardly any change. The 7% rise in share price for PAF:Pan Aftrican Resources boosted potential profits by £69 so not all bad news.

Same as ISA

Also well below trend line.

The trading account looks like this after week 287 overall and week 27 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£800.94	(-66.3%)	-£17.73
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.07	(7.6%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

The relentless drop continues. The portfolio is now two thirds down on purchase price, and that was over a year ago. Some great trading performance that is!

Utterly horrible

Not only following the trend line but below it.

I'm late writing up again, as my heart isn't in it. At the time of writing my portfolio has lost another £8,000 and 2022 is a catastrophe. I can't see it turning around before Friday so no doubt I'll be late writing this weeks up too.

Week 336 Review - Miserable start to 2022

A desperately bad week, with most of my big holdings taking big drops and the deficit between cost and value widening by £6,249 to £57,835 and portfolio value dropping below £100k to £97,764.

FXPO:Ferrexpo dropped 7%, probably due to the uncertain situation on the Ukraine border, despite FXPO being nowhere near that. It also went ex-dividend so at least there's some cash coming soon.

SBTX:SkinBioTherapeutics also dropped 7% as one of my worst timed purchases continues a downward spiral. News on sales or partner product development can't come soon enough, but all we have is silence.

BLU:Blue Star Capital was bound to ease off as people take profits following the recent rise. They dropped 5% of my original purchase price.

Biggest hit to value was OPTI:Optibiotix falling 5% which is 3p and contributed £5,100 of this week's drop. We're overdue so much news and it really needs to come soon.

Share of the Week was the only one to climb 5% or more as JLP:Jubilee Metals went up by 7% and seems to be slowly creeping up to where it should be.

Closest to the injection line for over a year.

Worst ever performance, just as I thought it couldn't get any worse.

Here's the ISA and shares portfolio after week 24 of year 7.

			Weekly Change
Cash	£33.30		+£0
Portfolio cost	£72,195.21		+£0
Portfolio sell value (bid price-commission)	£45,498.91	(-37.0%)	-£3,105.00
Potential profits	£2,275.29		+£60
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,664.29		+£0
Yr 7 projected avg monthly profit	£663.22	(18.0%)	-£27.80
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,788.23		+£0
Average monthly cash profit	£372.11	(10.1%)	-£1.12
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	65%		+0%

Massive drop in value but £60 increase in potential profits thanks to JLP:Jubilee Metals. Long term performance still above target.

As with the overall portfolio the closest to injection line for over a year.

Utterly desperate.

The SIPP looks like this after week 320 overall and week 8 of year 7.

			Weekly Change
Cash	£211.60		-£104.52
Portfolio cost	£80,526.94		+£104.52
Portfolio sell value (bid price - commission)	£50,943.19	(-36.7%)	-£3,086.92
Potential profits	£63.63		+£38.80
Yr 7 Dividends	£51.51		+£0
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£381.04		+£0
Yr 7 projected avg monthly profit	£216.15	(5.3%)	-£30.88
Total Dividends	£3,255.90		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£24,105.67		+£0
Average monthly cash profit	£358.94	(8.7%)	-£1.12
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	54%		+0%

Automatic investment in iShares Physical Gold fund reduced cash by £104 and increased portfolio cost. Massive drop in value but potential profits up £38 thanks to PAF:Pan African Resources. Long term performance needs a boost to get to target but there's no chance of that any time soon.

A familiar story

As with everything else, the worst performance ever.

The trading account looks like this after week 286 overall and week 26 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£818.67	(-65.5%)	-£57.35
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.12	(7.6%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

It goes without saying this is as bad as everything else, in fact significantly worse.

Urrrg.

Continues the relentless decline.

Late writing up this week as I'm so miserable. At the halfway point of this week the portfolio is down another £700 so it is still getting worse. All I can do is hang on and hope for some sort of recovery, but at the moment I can't see any rays of hope. Every time there's a tick upwards it's followed by a bigger drop. Good news is met by at best stagnation but more often with a drop in price. Nothing to do but steel oneself for the next disappointing update.

Week 335 Review - Declines across much of the portfolio

Not a great start to 2022, with some big falls across the portfolio resulting in a drop of £1,282 despite OPTI:Optibiotix staying flat. That extends the deficit between cost and value to £51,586 and reduces total value to £104,014.

The biggest faller was JLP:Jubilee Metals, although that does tend to happen almost every week due to my low purchase price. This week it dropped 11% but is still 254% up.

Next biggest faller is one of my most disappointing recent purchases POLY:Polymetal. It dropped 6% in the SIPP and 8% in the ISA mainly due to political concerns in Ukraine. However, FXPO:Ferrexpo is also in Ukraine and was up this week, so I think it's more that gold miners are just plain out of favour.

TLOU:Tlou Energy is still dropping a worrying amount, this week falling 7% for no clear reason. I'm happy with this as a long term investment, but it's too high risk for me to invest any more, even though it's temptingly cheap right now.

DDDD:4D Pharma continues to be an utter disaster, dropping another 6% this week to go 60% down on my purchase price. Even if it doubles from here I'll still be making a loss. I'm over £10,000 down now, having invested £16,641 making this my second biggest holding by a long way. I can't believe I was daft enough to believe listing on Nasdaq would cause a re-rate upwards, then it's more than halved in value since then.

It's not all doom and gloom this week. It seems the volatile market is helping PLUS:Plus500, which rose by 5% this week and is now only 11% down. Dividends are still rolling in and I don't need to review my holding until the end of May so plenty of time to get back into profit.

Share of the Week is BLU:Blue Star Capital which climbed another 14% as its recovery continues. I am now only 31% down, which compared to the rest of the portfolio isn't bad. Shame I only invested £500. I still think they are a bit rubbish so won't be putting any more in.

Almost flat.

Following the trend line downwards instead of trying to pull it flat.

Here's the ISA and shares portfolio after week 23 of year 7.

			Weekly Change
Cash	£33.30		-£3.75
Portfolio cost	£72,195.21		+£0
Portfolio sell value (bid price-commission)	£48,603.91	(-32.7%)	-£594.04
Potential profits	£2,215.29		-£100
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,664.29		+£0
Yr 7 projected avg monthly profit	£691.02	(18.8%)	-£32.14
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,788.23		+£0
Average monthly cash profit	£373.23	(10.1%)	-£1.16
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	65%		+0%

JLP:Jubilee Metals dropped by £100 to dent potential profits, and the rest of the portfolio lost £494. The ISA monthly charge reduced cash.

I so need this to start going up.

Still below the trend line and dragging it steeper.

The SIPP looks like this after week 319 overall and week 7 of year 7.

			Weekly Change
Cash	£316.12		+£86.38
Portfolio cost	£80,422.42		+£0
Portfolio sell value (bid price - commission)	£53,925.59	(-32.9%)	-£640.61
Potential profits	£24.83		-£22.77
Yr 7 Dividends	£51.51		+£0
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£381.04		+£0
Yr 7 projected avg monthly profit	£247.03	(6.0%)	-£53.22
Total Dividends	£3,255.90		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£24,105.67		+£0
Average monthly cash profit	£360.06	(8.8%)	-£1.36
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	54%		+0%

Cash went up after a £120 injection to my AJ Bell SIPP which hasn't been invested yet, but the monthly charges were also taken out and I did a bit of a re-set as my adding and subtracting payments must have missed a few lately and it had got out of sync. PAF:Pan African Resources is my only share in profit and that fell this week, so potential profits are a miserable £22. Long term performance is below target so I need my Magic Formula shares to wake up.

Pretty much the same as the ISA.

At least this one is fractionally above the trend line. I doubt this is flattening it much though.

The trading account looks like this after week 285 overall and week 25 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£876.02	(-63.1%)	-£47.91
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.17	(7.7%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

Good grief. Can this get any worse? Yet another big drop in value largely thanks to DDDD:4D Pharma. I haven't sold anything for a year - what sort of trading account does that? I'm utterly rubbish at it.

Move along please, nothing to see here.

I'm really impressed with how neatly we're following the trend line downwards.

We were expecting news from DDDD:4D Pharma, OPTI:Optibiotix and SBTX:SkinBioTherapeutics before Christmas, but it never appeared. Let's hope it comes soon in 2022 as these shares have the ability to turn around my current desperate performance very quickly, but only when the news hits.

Week 334 Review - A good end to the year thanks to Optibiotix

The final week of 2021 gave a little bit of seasonal cheer with a 3p rise in OPTI:Optibiotix resulting in a narrowing of the deficit between cost and value by £5,002. Unfortunately that means the rest of my portfolio was down by £100, but it's nice to see OPTI sneaking back upwards again on news of yet more deals and promise of some big ones in the new year. The deficit is now £50,303 and the total portfolio value is £105,214.

Looking back 12 months, the total value then was £120,024 which is £15k more than the current value, and I've added £11,555 during the year, so the total value is down by £26.5k in real terms. However last year there was a £12.7k rise in the last week of the year as OPTI:Optibiotix was soaring, but that turned out to be very short lived. I'll compare my long term performance stats against each account when I cover the numbers.

No big fallers this week, although a 2% drop in DDDD:4D Pharma was expensive and that is more than 50% down on my purchase price now.

BLU:Blue Star Capital climbed 5% and seems to have some momentum. It's only 45% down now. Will it ever get into profit?

OPTI:Optibiotix also climbed 5% after a torrid few months. If we can just get established back in the 50's then that will help remove a big chunk of my losses until we get the longer term re-rate.

Share of the Week is JLP:Jubilee Metals which climbed 7%. I'm a bit nervous about the short term prospects as they are talking about a new global expansion plan, and that could result in a placing - particularly as institutions are probably pushing for one if they want to get in and are not prepared to buy on the open market. One of the problems with the management board having practically no shares is the temptation for continued dilution. I need a war chest as I think it would be worth buying more if there's a big drop following a placing announcement.

A good bounce, but we're still below the value 3 weeks ago,

Bang on the trend line so at least it's not getting steeper

Here's the ISA and shares portfolio after week 22 of year 7.

			Weekly Change
Cash	£37.05		+£0
Portfolio cost	£72,195.21		+£0
Portfolio sell value (bid price-commission)	£49,197.95	(-31.9%)	+£2,583.71
Potential profits	£2,315.29		+£60
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,664.29		+£0
Yr 7 projected avg monthly profit	£723.16	(19.6%)	-£34.44
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,788.23		+£0
Average monthly cash profit	£374.39	(10.2%)	-£1.13
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	65%		+0%

JLP:Jubilee Metals increased potential profits by £60, value up nicely thanks to OPTI:Optibiotix and long term performance still above target at 10.2% compared to 9.8% this time last year. So although the portfolio value itself is down 31.9% rather than only 8% last year, performance on selling shares and dividends is slightly better.

Very similar to combined chart

Still below the trend line so still dragging it steeper.

The SIPP looks like this after week 318 overall and week 6 of year 7.

/>

			Weekly Change
Cash	£229.74		+£40.31
Portfolio cost	£80,422.42		+£30.00
Portfolio sell value (bid price - commission)	£54,566.20	(-32.2%)	+£2,439.07
Potential profits	£47.60		+£32.31
Yr 7 Dividends	£51.51		+£10.31
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£381.04		+£0
Yr 7 projected avg monthly profit	£300.25	(7.3%)	-£51.12
Total Dividends	£3,255.90		+£10.31
Total Interest	£0.20		+£0
Total Profit from sales	£24,105.67		+£0
Average monthly cash profit	£361.42	(8.8%)	-£1.00
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	54%		+0%

Cash increased following a £30 tax rebate in my AJ Bell account and a £10.31 dividend from WHR:Warehouse REIT. There was also a £30 tax rebate in my Hargreaves Lansdown account, and that automatically invested in Blackrock World Gold fund. That's the last of these, so I'll sell at some point soon so I'll only have the one gold fund in my other account. Potential profits are mainly up thanks to PAF:Pan African Resources. The only other thing in profit is iShares Physical Gold, but that's only contributing £1. Great rise in value as with the ISA, and long term performance still ok at 8.8% compared with 8.6% this time last year. The account was only 3.7% in deficit last year compared to 32.2% this year.

Same shape as the ISA

Above the trend line so let's hope we can start pulling it upwards.

The trading account looks like this after week 284 overall and week 24 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£923.93	(-61.1%)	-£20.30
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.23	(7.7%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

The drop in DDDD:4D Pharma hit this account yet again. I desperately need some news from them. Long term performance is at 7.7% compared to 8.6% this time last year which was just after selling a load for profit and re-investing in DDDD. A whole year since that terrible mistake. The account was 16.6% down compared to 61.1% down now.

Not the lowest ever but not far off.

Fractionally above the trend line but following it down.

2021 has been a good year for improving long term performance, with the main accounts both making more from realised profits and dividends than at the start of the year. However it has been a desperate year for portfolio value, with nearly everything I own making a loss, including all bar 1 of my magic formula shares.

My biggest holdings are OPTI:Optibiotix and DDDD:4D Pharma, which have both been hammered this year. My magic formula shares are mostly split between share trading companies which crashed when one of their peers gave a profit warning, and gold miners that are being hammered despite gold being above $1,800.

Let's hope 2022 is kinder to my portfolio holding and we can get back towards break-even.